Receive $200 for creating an Interactive Brokers account using our link: Create IBKR account. Read our Interactive Brokers analysis

Ticker
GLTO

Price
29.58
Stock movement up
+1.41 (5.01%)
Company name
Galecto Inc
Exchange
(NASDAQ
,
Currency
USD
)
Sector
Healthcare >
Biotechnology
Market cap
47.11M
Ent value
43.57M
Price/Sales
-
Price/Book
7.07
Div yield
-
Div growth
-
Growth years
-
FCF payout
-
Trailing P/E
-
Forward P/E
-
PEG
-
EPS growth
-31.96%
1 year return (CAGR)
413.54%
3 year return (CAGR)
-
5 year return (CAGR)
-
10 year return (CAGR)
-
Last updated: 2026-01-22

iO Charts is a Seeking Alpha partner

iO Charts is a Seeking Alpha partner

DIVIDENDS

GLTO does not pay dividends or no data was received

iO Charts is a Seeking Alpha partner

iO Charts is a Seeking Alpha partner

VALUATION

Valuation Ratios

Loading...
Valuation Ratios data
Trailing P/E-
Price to OCF-
Price to FCF-
Price to EBITDA-
EV to EBITDA-

Valuation (Sales/Book Value)

Loading...
Valuation (Sales/Book Value) data
Price to Sales-
Price to Book7.07
EV to Sales-

iO Charts is a Seeking Alpha partner

iO Charts is a Seeking Alpha partner

FINANCIALS

Per share

Loading...
Per share data
Current share count1.59M
EPS (TTM)-11.94
FCF per share (TTM)-9.21

Income statement

Loading...
Income statement data
Revenue (TTM)0.00
Gross profit (TTM)-14.00K
Operating income (TTM)-11.88M
Net income (TTM)-15.84M
EPS (TTM)-11.94
EPS (1y forward)-1.56

Margins

Loading...
Margins data
Gross margin (TTM)-
Operating margin (TTM)-
Profit margin (TTM)-

Balance Sheet

Loading...
Please create a free account or log in to access this chart
Balance Sheet data
Cash7.61M
Net receivables992.00K
Total current assets9.79M
Goodwill0.00
Intangible assets0.00
Property, plant and equipment180.00K
Total assets10.74M
Accounts payable520.00K
Short/Current long term debt1.41M
Total current liabilities2.62M
Total liabilities4.07M
Shareholder's equity6.67M
Net tangible assets0.00

Cash flow

Loading...
Please create a free account or log in to access this chart
Cash flow data
Operating cash flow (TTM)-12.23M
Capital expenditures (TTM)0.00
Free cash flow (TTM)-12.23M
Dividends paid (TTM)0.00

Financial returns

Loading...
Please create a free account or log in to access this chart
Financial returns data
Return on Equity-237.68%
Return on Assets-147.58%
Return on Invested Capital-237.15%
Cash Return on Invested Capital-183.03%

iO Charts is a Seeking Alpha partner

iO Charts is a Seeking Alpha partner

STOCK INFORMATION

Stock chart

Loading...
Stock price data
Open29.36
Daily high32.00
Daily low28.77
Daily Volume37K
All-time high421.00
1y analyst estimate32.00
Beta1.41
EPS (TTM)-11.94
Dividend per share0.00
Ex-div date-
Next earnings date-

Downside potential

Loading...
Downside potential data
GLTOS&P500
Current price drop from All-time high-92.97%-0.89%
Highest price drop-99.47%-19.00%
Date of highest drop10 Apr 20258 Apr 2025
Avg drop from high-98.17%-2.49%
Avg time to new high-6 days
Max time to new high322 days89 days

iO Charts is a Seeking Alpha partner

iO Charts is a Seeking Alpha partner

COMPANY DETAILS
GLTO (Galecto Inc) company logo
Marketcap
47.11M
Marketcap category
Small-cap
Description
Galecto, Inc., a clinical-stage biotechnology company, develops molecule therapeutics for the treatment of fibrosis, cancer, inflammation, and other related diseases. The company develops GB3226, a preclinical small molecule dual inhibitor of ENL-YEATS and FLT3 and GB1211, an oral small molecule inhibitor of galectin-3 to treat multiple types of oncology and liver disease indications. Galecto, Inc. was founded in 2011 and is headquartered in Copenhagen, Denmark.
Employees
5
Investor relations
-
SEC filings
CEO
Country
USA
City
Stock type
-
CCC status
-
Dividend Frequency
-
EVENTS AND PRESENTATIONS
EventsPresentations
Loading...

iO Charts is a Seeking Alpha partner

iO Charts is a Seeking Alpha partner

UNDERSTAND THE BUSINESS
Loading...